These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Detection of HTLV-III antibodies using ELISA and the western blot]. Kunz C; Heinz FX Wien Klin Wochenschr; 1985 Nov; 97(22):829-32. PubMed ID: 3002046 [TBL] [Abstract][Full Text] [Related]
23. [Prevalence of antibodies against LAV/HTLV-III in patients with terminal renal insufficiency treated with hemodialysis and following renal transplantation]. Fassbinder W; Kühnl P; Neumayer HH; Offermann G; Seidl S; Schoeppe W Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1087-90. PubMed ID: 3015545 [TBL] [Abstract][Full Text] [Related]
24. Detection of antibody to HTLV-III by commercial kits. O'Shaughnessy MV; Benning BJ; Neumann PW CMAJ; 1985 Sep; 133(6):551, 555. PubMed ID: 2992733 [No Abstract] [Full Text] [Related]
25. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. Blumberg RS; Sandstrom EG; Paradis TJ; Neumeyer DN; Sarngadharan MG; Hartshorn KL; Byington RE; Hirsch MS; Schooley RT J Clin Microbiol; 1986 Jun; 23(6):1072-7. PubMed ID: 2423552 [TBL] [Abstract][Full Text] [Related]
26. Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test. Jungkind DL; DiRenzo SA; Young SJ J Clin Microbiol; 1986 Feb; 23(2):381-2. PubMed ID: 3009536 [TBL] [Abstract][Full Text] [Related]
27. [Immunofluorescence in the serological study of HTLV-III/LAV]. Picchio G; Muchinik G Medicina (B Aires); 1986; 46(2):247-8. PubMed ID: 3033429 [No Abstract] [Full Text] [Related]
28. Western blot technique in the serological evaluation of three LAV/HTLV III-infected Italian families. Geroldi D; Aricò M; Plebani A; Maccario R; Notarangelo LD; Duse M; Rey F; Barrè Sinoussi F; Chermann JC; Burgio GR Infection; 1986; 14(2):60-3. PubMed ID: 3011677 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of EIA kits for the detection of HIV antibodies. Ovcak S; Drinovec B; Likar M Acta Virol; 1987 Sep; 31(5):434-8. PubMed ID: 2891282 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of five commercial assays for the detection of anti-dsDNA antibodies: three Crithidia luciliae indirect immunofluorescence test kits and two enzyme immunoassay kits. Viriyataveekul R; Kobkitjaroen J; Jaiyen J; Kongkriengdach S; Potprasart S J Med Assoc Thai; 2014 Feb; 97(2):220-4. PubMed ID: 24765902 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III]. Heinz FX; Kunz C; Barrett N Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of antibodies to HTLV-III in quality-assurance sera. Howanitz PJ; McBride JH; Kliewer KE; Rodgerson DO Clin Chem; 1986 May; 32(5):773-7. PubMed ID: 3009051 [TBL] [Abstract][Full Text] [Related]
33. Comparison of six commercial human T-cell lymphotropic virus type I (HTLV-I) enzyme immunoassay kits for detection of antibody to HTLV-I and -II. Cossen C; Hagens S; Fukuchi R; Forghani B; Gallo D; Ascher M J Clin Microbiol; 1992 Mar; 30(3):724-5. PubMed ID: 1551991 [TBL] [Abstract][Full Text] [Related]
34. [Antibodies against human T-cell leukemia virus type III in acquired immunodeficiency syndrome and persistent lymphadenopathy]. Wernicke D; v d Helm K; Abb J; Eberle J; Zoulek G; Pleyl G; Deinhardt F; Riethmüller G; Ziegler-Heitbrock HW; Rieber EP Dtsch Med Wochenschr; 1984 Nov; 109(45):1709-11. PubMed ID: 6094134 [TBL] [Abstract][Full Text] [Related]
35. Human T-cell lymphotropic virus type I infection in neonates. Hara T; Takahashi Y; Sonoda S; Kusuhara K; Ueda K Am J Dis Child; 1987 Jul; 141(7):764-5. PubMed ID: 2884867 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the indirect immunofluorescence assay as a confirmatory test for detecting antibodies to the human immunodeficiency virus. McHugh TM; Stites DP; Casavant CH; Carlson JR; Yee J; McVay PA; Busch MP; Levy JA Diagn Immunol; 1986; 4(5):233-40. PubMed ID: 3539456 [TBL] [Abstract][Full Text] [Related]
37. [Detection of anti-cytomegalovirus antibodies: comparison of 3 commercial methods]. García-Aguayo JM Sangre (Barc); 1990 Dec; 35(6):475-6. PubMed ID: 1965060 [TBL] [Abstract][Full Text] [Related]
38. Detection of anti-HTLV III: modification of a commercial enzyme immunoassay. Barr A; Muir W; Dow BC; Arnott J; Macvarish IP Med Lab Sci; 1987 Jan; 44(1):97-9. PubMed ID: 3309535 [No Abstract] [Full Text] [Related]
39. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592 [TBL] [Abstract][Full Text] [Related]
40. Comparison of commercial kits for the detection of antibody to human immunodeficiency virus type 1 (HIV-1) in Nigeria. Chikwem JO; Mohammed I; Ola TO East Afr Med J; 1990 Mar; 67(3):209-13. PubMed ID: 2191859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]